ClinicalTrials.Veeva

Menu

The Effect of a Liquid Protein Modular on Growth and Outcomes in the NICU

University of Nebraska logo

University of Nebraska

Status

Completed

Conditions

Problem With Growth of an Infant

Treatments

Dietary Supplement: Liquid protein modular
Dietary Supplement: Powder protein modular

Study type

Interventional

Funder types

Other

Identifiers

NCT01609868
12-16432

Details and patient eligibility

About

The investigators hypothesis that premature infants receiving a commercially available liquid protein modular will have improved growth when compared with premature infants receiving a commercially available powder protein modular.

Enrollment

60 patients

Sex

All

Ages

Under 40 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Infants less than 2000 gms at birth, receiving maternal breast milk

Exclusion criteria

  • Infants receiving formula

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

60 participants in 2 patient groups

control
Active Comparator group
Description:
infants in this arm will receive the current treatment that is standard of care for these infants, powder protein modular to achieve 4 gm/kg/day
Treatment:
Dietary Supplement: Powder protein modular
experimental
Experimental group
Description:
this group will receive a liquid protein modular that recently became commercially avaliable, to achieve the same protein of 4 grm/kg/day as the powder comparision group
Treatment:
Dietary Supplement: Liquid protein modular

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems